The patient advocacy group alleges that Cancard, which markets itself as a form of medical cannabis ID, is misleading vulnerable patients as it provides no legal protection for cannabis possession under UK law, and has reported them to the police. This story first appeared on leafie, [...]
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing campaigns, but in clinics, in consultations, and in the steady accumulation of patient outcomes. At Releaf, [...]
The country’s medicines regulator has approved its first psychiatrist to prescribe psilocybin for treatment-resistant depression outside of clinical trials, providing a new option for patients who have exhausted conventional therapies. This story first appeared on leafie, view here Author: Liam O'Dowd
Patients in Australia living with endometriosis say cannabis is more-effective for managing their symptoms, and has fewer side-effects than pharmaceutical medications, a new survey finds. According to new survey data published in the journal Reproduction & Fertility, the majority of patients using cannabis to manage symptoms of endometriosis, find [...]
Ukraine has officially issued its first ever permit for medical cannabis to be imported into the country, bringing patients one step closer to receiving treatment. It represents the latest development in Ukraine’s nascent but rapidly evolving medical cannabis programme, after the country officially enshrined it into law [...]
Ahead of European Cannabis Week, Grow Group’s Managing Director, Pierre van Weperen, talks to Cannabis Health about the current state of play, and the future of cannabis-based medicine in the UK. More than 6.4 million people in the UK are currently waiting for treatment on the [...]
International research involving 889 women finds cannabis has fewer side effects and provides greater relief from pain, but stigma and legal barriers prevent disclosure to doctors. This story first appeared on leafie, view here Author: Kevin Dinneen
A national class action has been brought against Aurora Cannabis in Canada, alleging that the company ‘negligently’ failed to warn consumers about the risk of developing Cannabinoid Hyperemesis Syndrome (CHS). On May 14, 2025, the Ontario Superior Court of Justice certified a national class action alleging [...]
The well respected advocate will be offering support and guidance to patients while continuing to fight for improved rights for cannabis users. This story first appeared on leafie, view here Author: Kevin Dinneen
A profound change is quietly occurring across the UK, writes James Smith, medical cannabis patient and co-founder of 4C Labs, following a recent experience using cannabis-based medicines to recover from major hip surgery on the NHS. Disclaimer: I am not a doctor or a scientist, this [...]
Joel Cunningham was given a suspended sentence after a judge acknowledged the cannabis oils and creams he supplied had "given people hope". This story first appeared on leafie, view here Author: Liam O'Dowd
A new UK study highlights how medical cannabis may improve quality of life for people living with obsessive compulsive disorder (OCD). Researchers at Drug Science analysed data from what they believe to be the largest sample of OCD patients receiving cannabis-based medicines on prescription. OCD is estimated [...]
Cannabis remains Europe's most widely used illicit drug, with the market valued at €12.1 billion annually, according to new European Union data. This story first appeared on leafie, view here Author: Kevin Dinneen
Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical Diseases (PLOS NTDs), researchers discovered that Cannabidiol (CBD) and Cannabidivarin (CBDV) killed harmful Cryptococcus neoformans – a WHO-listed priority fungal pathogen. [...]
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products. Seven years since the first unlicensed cannabis-based medicinal products (CBPMs) were prescribed in the UK, the [...]
The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person. Its [...]
Commander Julian Bennett was originally sacked by the Met Police for refusing a drugs test in 2020, after it was alleged he took cannabis, LSD and magic mushrooms while on holiday in France. This story first appeared on leafie, view here Author: Liam O'Dowd
Cannabis use among older adults in the US has reached a new high, with 7% of adults aged 65 and over who report using it in the past month. This is according to an analysis led by researchers with the Center for Drug Use and HIV/HCV [...]
From 2026 adults over 21 will be allowed to cultivate up to three cannabis plants per person, keep up to 100 grams of dried cannabis at home and possess up to 25 grams in public. This story first appeared on leafie, view here Author: Kevin Dinneen
Every year, Men’s Health Week serves as a crucial reminder to pause and reflect on the health challenges that many men face – but often don’t talk about. It’s a time to raise awareness of how gender, culture and environment can affect our health, and to [...]
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical foundations. That means investing not just in science or access, but in a new generation of [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
